Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Current Provider-Administered Oncology Drug Policies .

Abraxane, Paclitaxel Albumin-Bound

print Print Back Back Adcetris® (brentuximab vedotin) (Intravenous) Policy Number: VP-004 Last Review Date:...

Halaven

Alimta, Pemfexy, Pemetrexed

print Print Back Back Immune Globulins (immunoglobulin) (Intravenous) Policy Number: VP-0071 Last Review Date:...

print Print Back Back Ixempra® (ixabepilone) (Intravenous) Policy Number: VP-0072 Last Review Date:...

Jevtana, Cabazitaxel

print Print Back Back Aloxi® (palonosetron) (Intravenous) Policy Number: VP-008  Last Review Date:...

print Print Back Back Nplate™ (romiplostim) (Subcutaneous) Policy Number: VP-0089 Last Review Date:...

print Print Back Back Kadcyla® (ado-trastuzumab emtansine) (Intravenous) Policy Number: VP-0092 Last...

print Print Back Back Perjeta® (pertuzumab) (Intravenous) Policy Number: VP-0096 Last Review Date:...

print Print Back Back Provenge® (sipuleucel-T) (Intravenous) Policy Number: VP-0100 Last Review Date:...

print Print Back Back Rituximab: Rituxan®, Truxima®, Ruxience®, Riabni™ (Intravenous) Policy Number: VP-0109...

print Print Back Back Bendamustine: Treanda®; Bendeka®; Belrapzo®; Vivimusta™; Bendamustine Ψ (Intravenous)...

print Print Back Back Vectibix® (panitumumab) (Intravenous) Policy Number: VP-0136 Last Review Date:...

print Print Back Back Bevacizumab: Avastin®; Mvasi®; Zirabev™; Alymsys®; Vegzelma™ (Intravenous) Policy...

print Print Back Back Yervoy™ (ipilimumab) (Intravenous) Policy Number: VP-0148 Last Review Date:...

Synribo

print Print Back Back Kyprolis® (carfilzomib) (Intravenous) Policy Number: VP-0157 Last Review Date:...

print Print Back Back Zaltrap® (ziv-aflibercept) (Intravenous) Policy Number: VP-0161 Last Review Date:...